Roche's Genentech is warning oncologists that counterfeiters are making and selling fake Avastin in the US, reports the Associated Press' Matthew Perrone. Although it's unclear how many vials of the counterfeit drug have been distributed, a company spokeswoman said some have gone to healthcare facilities, Perrone adds.
Chanel? Vuitton? Avastin?
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.